Navigational Bronchoscopy or Transthoracic Needle Biopsy for Lung Nodules.

9 major claims checked against the paper's own evidence: all adequately supported.

Recomputed 1 test: 1 consistent, 0 inconsistent, 1 via agent-written checks.

2 integrity concerns flagged (0 high).

1 copyedit issue flagged: mostly consistency.

Checked 26 references: 22 verified — 4 not checked.

2 data/code links checked; 2 live.

The manuscript is close to submission-ready but requires two critical additions (data availability statement, ethics regulation statement) and several medium-priority fixes before it clears a journal's pre-submission checks.

1. 1.
   HIGHdata code

   Add a Data Availability section before the References stating how de-identified patient data can be accessed (e.g., 'De-identified participant data will be shared on reasonable request to the corresponding author, subject to a data use agreement.')

   A data availability statement is a journal requirement; its absence is likely to trigger a mandatory revision or return.
2. 2.
   HIGHethics

   Add a sentence in the Methods (Trial Design and Oversight) explicitly stating that the trial was conducted in accordance with the Declaration of Helsinki (or applicable local regulations).

   The paper reports IRB approval but omits the standard regulatory-compliance statement, which reviewers and editors universally expect.
3. 3.
   HIGHreporting

   Fix the abstract so that the per-group denominators (119 + 110 = 229) reconcile with the reported total of 234 patients in the primary analysis, by adding a clarifying sentence (e.g., 'Five patients were lost to follow-up and were excluded from the primary analysis.')

   The discrepancy (234 vs 229) is a consistency error that a careful copyeditor or reviewer will catch and question.
4. 4.
   HIGHreporting

   Reference a reporting guideline (CONSORT) in the Methods, and submit a completed CONSORT checklist as supplementary material.

   Journals typically require submission of a completed reporting checklist; its absence is a procedural gap.
5. 5.
   HIGHrigor

   Specify the type, gauge, and size of the biopsy needle(s) used for transthoracic biopsy in the Methods (Trial Intervention).

   The needle specification is a key resource detail needed for reproducibility; its absence was flagged by one reviewer.
6. 6.
   HIGHstatistics

   Report exact p-values (e.g., 0.0045) for all secondary safety outcomes in Table 3 and the text, replacing threshold values like 'p<0.01'.

   Precise p-values allow readers to assess the strength of evidence; threshold reporting is a common reviewer criticism.
7. 7.
   HIGHstatistics

   Add a sentence in the Methods (Statistical Analysis) describing any assumption checks performed for the primary z-test (e.g., normality of the difference distribution or the use of a large-sample approximation).

   Statistical test assumptions are part of rigorous reporting even when the test is robust to moderate violations.
8. 8.
   MEDIUMreporting

   Provide a brief justification for the chosen noninferiority margin of 10 percentage points, citing a clinical precedent or a consensus statement.

   A noninferiority margin should be clinically justified; its absence can be questioned during review.
9. 9.
   MEDIUMreporting

   Describe the software used for the sample-size calculation (e.g., nQuery, PASS) and any key assumptions (e.g., expected event rate) in the Methods.

   Transparency in sample-size software and assumptions strengthens the power analysis reporting.
10. 10.
    MEDIUMdata code

    Share custom analysis code (e.g., R scripts for the primary noninferiority test and key figures) in a public repository (e.g., Zenodo, GitHub) and include the DOI or link in the manuscript.

    Code sharing supports computational reproducibility, even though it is not universally required; it is a best practice increasingly expected by journals.
11. 11.
    LOWreporting

    Add a sentence in the Discussion about generalizability of the results to non-academic centers with less experienced bronchoscopists.

    The trial was conducted at tertiary academic centers; acknowledging this limitation helps readers interpret the applicability of findings.